Vanta Bioscience Ltd

(540729)

Vanta Bioscience Limited (VBS) is an Indian preclinical contract research organization established in 2016, specializing in preclinical safety assessments services for the Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics and Chemical industries. It provides risk assessment services and expert services which involve the determination of health based exposure limits such as permitted daily exposure (PDE) and allowable daily exposure (ADE), including occupational exposure limits (OEL). VBS has state-of-the-art preclinical CRO facilities set up in Gummidipundi, Chennai, and conducts a variety of in vivo and in vitro studies for its clients as they strive for regulatory approval worldwide. Their services also involve preclinical proof-of-concept (POC) studies which involve the validation of new pharmaceuticals and products intended for novel indications. With a dedicated team of promoters and experienced researchers, VBS continues to be a major player in the preclinical research space in India.

Share Price: ₹42.47 per share as on 27 Dec, 2024 04:01 PM
Market Capitalisation: ₹26.81Cr as of today
Revenue: ₹0.63Cr as on March 2023 (Q1 23)
Net Profit: ₹-1.36Cr as on March 2023 (Q1 23)
Chairperson Name: Mohan Krishna Mulakala